EUVIMEDEUVIMED entdecken
Crossref

Mapping the scope of drug patents

Janet Freilich, Kasper Dinkla, Gerhard Ingmar Meijer, Lisa Larrimore Ouellette

Science · 29.10.2026 · 394 (6823) · 496-498

DOI: 10.1126/science.aeh0691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 29.10.2026. Verfasst von Janet Freilich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Boston University School of Law, Boston, MA, USA. Hauptthemen laut MEDLINE: Patents as Topic, Drug Industry. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Narrowing patents that claim more than they disclose would open space for rival innovators, not generics

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patents as TopicDrug IndustryDrugs, GenericUnited States

Substanzen

Drugs, Generic

Autor:innen und Institutionen

  • Boston University School of Law, Boston, MA, USA.
  • IBM Research-Zurich, Rüschlikon, Switzerland.
  • Stanford Law School, Stanford University, Stanford, CA, USA.

Zitieren

APA

Freilich, J., Dinkla, K., Meijer, G. I., & Ouellette, L. L. (2026). Mapping the scope of drug patents. Science, 394(6823), 496-498. https://doi.org/10.1126/science.aeh0691

Vancouver

Freilich J, Dinkla K, Meijer GI, Ouellette LL. Mapping the scope of drug patents. Science. 2026;394(6823):496-498. doi:10.1126/science.aeh0691

BibTeX
@article{Freilich2026,
  author = {Freilich, Janet and Dinkla, Kasper and Meijer, Gerhard Ingmar and Ouellette, Lisa Larrimore},
  title = {Mapping the scope of drug patents},
  journal = {Science},
  year = {2026},
  volume = {394},
  number = {6823},
  pages = {496--498},
  doi = {10.1126/science.aeh0691}
}
Kostenlos starten →